NSCLC tissues; adjacent normal tissue samples; tumor tissues
H522; A549; H1299; H460; BEAS-2B; LLC
cell line-derived xenograft; syngeneic model
proliferation (promotes); migration (promotes); invasion (promotes); EMT (promotes); apoptosis (inhibits); TGF-beta/SMAD (promotes); mRNA stability (promotes); immune regulation (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Microarray; FISH / smFISH; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Flow Cytometry(Non-apoptosis/cycle); Transwell Assay; In Vivo Animal Model; IF (Immunofluorescence); Western Blot; Bioinformatics Analysis
hsa_circ_0002360 overexpression was significantly associated with advanced TNM stages and distant metastasis in NSCLC, suggesting potential therapeutic value.
hsa_circ_0002360 is up-regulated in NSCLC tissues and cell lines and is associated with advanced TNM stage and distant metastasis. Functionally, it promotes proliferation, invasion, migration, EMT, tumor growth and immune evasion while suppressing apoptosis. Mechanistically, it interacts with HNRNPA1, enhances HNRNPA1 mRNA stability, and activates PD-L1/TGF-beta-related immune evasion programs.
0.8355
Has_circ_0002360 facilitates immune evasion by enhancing heterogeneous nuclear ribonucleoprotein A1 stability, thereby promoting malignant progression in non-small cell lung cancer.
combined biological and clinical study